Management of Alpha-Gal Syndrome
The management of Alpha-Gal Syndrome (AGS) primarily involves complete avoidance of all mammalian meat products and mammalian-derived products, with safe alternatives including fish, seafood, poultry, and plant-based foods. 1
Diagnosis Confirmation
- Diagnosis should be confirmed with:
- Serum testing for alpha-gal IgE antibodies (positive result >0.1 IU/mL)
- Clinical correlation with symptoms (delayed reactions 3-6 hours after mammalian product consumption)
- Improvement of symptoms after adherence to an alpha-gal avoidance diet 1
Management Protocol
Dietary Restrictions
- Complete avoidance of all mammalian meat products including:
- Beef, pork, lamb, venison, rabbit, and other red meats
- Mammalian organ meats
- Products containing mammalian-derived ingredients
- Caution with dairy products (typically cause milder reactions but may still affect sensitive individuals) 1
- Safe food alternatives:
- Fish and seafood
- Poultry (chicken, turkey)
- Plant-based foods 1
Medication Management
- Prescribe epinephrine auto-injector for patients with history of systemic reactions 1
- Recommend antihistamines for management of milder reactions 1
- Avoid medications containing alpha-gal such as:
Tick Bite Prevention
- Essential to prevent worsening of the allergy:
Follow-Up and Monitoring
- Repeat alpha-gal IgE levels 6-12 months after diagnosis if tick bites are avoided 2, 1
- Monitor for symptom improvement after dietary elimination
- As IgE levels decrease or become negative, patients may be able to gradually reintroduce:
- First, small amounts of low-fat dairy products
- Then, lean mammalian meat in small portions 2
Important Considerations
- Reactions can be inconsistent - patients may tolerate red meat occasionally but still have AGS 2
- Co-factors that increase reaction risk and severity:
- Fattier cuts of meat
- Nonsteroidal anti-inflammatory drugs
- Exercise
- Alcohol consumption 2
- Reintroduction protocol:
When to Refer to an Allergist
Refer patients to an allergist when they report:
- Skin or systemic changes
- Swelling of face or throat
- Voice changes
- Difficulty breathing
- Hives
- Fainting with reactions 2
Emerging Treatment Options
While avoidance remains the primary management strategy, limited evidence suggests potential future treatments:
- Oral immunotherapy has shown promise in small studies but is not yet standard practice 3
- No established desensitization protocols are currently recommended by major guidelines 2
Alpha-gal syndrome is often underdiagnosed due to limited awareness among healthcare providers, with 42% of surveyed providers having never heard of AGS 4. Therefore, increased education and awareness are essential components of improving patient care.